Online citations, reference lists, and bibliographies.
← Back to Search

Treatment Of Malignant Pleural Mesothelioma: Lessons Learned And Quo Vadis?

S. Boeluekbas, M. Eberlein
Published 2018 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Macroscopic complete resection (MCR) is the goal of surgery and seems to have the most significant effect on survival in patients undergoing surgery-directed multimodality treatment (MMT) for malignant pleural mesothelioma (MPM) (1). For the authors, it is not questionable that Dr. David J. Sugarbaker and his team had, have and will have a significant impact on the term MCR and the surgery-directed MMT, respectively.
This paper references
10.1136/thx.31.1.15
Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.
E. Butchart (1976)
10.1016/S1556-0864(15)31536-7
Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma.
D. Sugarbaker (2006)
10.1177/0218492312454017
Changes in lung function after surgery for mesothelioma
T. Ploenes (2013)
10.1093/ANNONC/MDM027
Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
C. Manegold (2007)
10.1016/j.athoracsur.2012.05.102
Quality of life after radical pleurectomy decortication for malignant pleural mesothelioma.
N. Mollberg (2012)
10.1097/JTO.0b013e31824de2dc
Prospective Study on Functional Results After Lung-Sparing Radical Pleurectomy in the Management of Malignant Pleural Mesothelioma
S. Boeluekbas (2012)
10.1093/icvts/ivw422
Propensity matched comparison of extrapleural pneumonectomy and pleurectomy/decortication for mesothelioma patients.
Arthur Kostron (2017)
10.1016/S1470-2045(11)70149-8
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
T. Treasure (2011)
10.1016/j.athoracsur.2012.02.009
Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma.
J. Friedberg (2012)
10.1097/JTO.0000000000000078
A Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy: The “SMART” Approach for Resectable Malignant Pleural Mesothelioma
B. Cho (2014)
10.1183/09031936.00063109
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
A. Scherpereel (2009)
10.1016/1010-7940(91)90142-7
Diagnostic and therapeutic strategy in malignant pleural mesothelioma.
D. Branscheid (1991)
10.1016/j.lungcan.2009.08.019
Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy.
S. Boeluekbas (2011)
10.1056/nejmoa051185
Asbestos exposure, pleural mesothelioma, and serum osteopontin levels.
H. Pass (2005)
10.1016/j.lungcan.2013.11.026
A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma.
C. Cao (2014)
10.1038/ng.912
Germline BAP1 mutations predispose to malignant mesothelioma
J. Testa (2011)
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines
Hodgkin Lymphoma (2014)
10.1200/JCO.2003.11.136
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
N. Vogelzang (2003)
10.1016/j.jtcvs.2015.09.121
Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy.
H. Batırel (2016)
10.1634/THEONCOLOGIST.12-10-1215
Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002).
G. Fasola (2007)
Extrapleural pneumonectomy versus pleurectomy in the surgical management of malignant pleural mesothelioma: Results in 663 patients
RM Flores (2008)
10.1183/13993003.01428-2016
Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma
M. D. de Perrot (2017)
10.1093/ejcts/ezt082
Thoracic shaping technique to avoid residual space after extended pleurectomy/decortication.
S. Boeluekbas (2013)
Guidelines in Oncology (NCCN Guidelines): Malignant Pleural Mesothelioma
NCCN Clinical Practic (2011)
10.1016/j.jtcvs.2014.10.041
Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience.
L. Lang-Lazdunski (2015)
10.1510/icvts.2010.251488
A survey of opinions and beliefs concerning surgery for malignant pleural mesothelioma amongst 802 members of the European Association for Cardio-Thoracic Surgery (EACTS), the European Society of Thoracic Surgeons (ESTS) and the Society of Thoracic Surgeons (STS).
T. Treasure (2011)
10.1056/NEJMoa1115050
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.
H. Pass (2012)
Latent period for malignant mesothelioma of occupational origin.
B. Lanphear (1992)
Radical Pleurectomy and Intraoperative Photodynamic Therapy 1185 Journal of Thoracic Disease, Vol 10, No 3 March 2018 © Journal of Thoracic Disease
JS Friedberg (2018)
10.21037/jtd.2018.02.75
New concepts in the treatment of malignant pleural mesothelioma.
M. Lapidot (2018)
10.1093/ejcts/ezv403
The effects of an intentional transition from extrapleural pneumonectomy to extended pleurectomy/decortication.
A. Sharkey (2016)
10.1200/JCO.2011.39.6671
Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis.
Kevin Hollevoet (2012)



Semantic Scholar Logo Some data provided by SemanticScholar